Try our beta test site

Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects

This study has been terminated.
(Terminated new protocol developed which incorporated Pharmacokinetics)
Information provided by (Responsible Party):
Endo Pharmaceuticals Identifier:
First received: October 2, 2008
Last updated: June 10, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)